Le RPE de Ayala Pharmaceuticals Inc. est $11.111k
Le revenu par employé (RPE) est le revenu divisé par le nombre d'employés d'une organisation.
advaxis (nasdaq: adxs) is a late -stage biotechnology company developing multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer. the advaxis technology, using bioengineered live attenuated bacteria, listeria monocytogenes (lm), actively suppresses key components in the tumor microenvironment that contribute to the tumors growth and protection from immunologic attack.